Abstract:The present work describes the synthesis and docking of heterocyclically substituted glycinamide derivatives. These derivatives are assessed in vitro for DPP 4 inhibition. Compound 2‐(4‐fluorophenethylamino)‐1‐(4‐(6‐fluorobenzo[d]isoxazol‐3‐yl)piperidin‐1‐yl)ethan‐1‐one (JAG‐D2), showing promising results during in vitro assessment was evaluated in vivo using OGTT assay in streptozotocin‐induced diabetic rats. The structure‐activity relationship studies based the binding mode of glycinamide derivatives and MD simulation of JAG‐D2 are discussed. According to the International Diabetes Federation, the global prevalence of diabetes is projected to increase to 643 million individuals by 2030 and 783 million by 2045. DPP 4 inhibitors approved by regulatory authorities worldwide, efficiently to regulate high blood sugar levels by impeding the degradation of glucagon like peptide‐1 (GLP‐1), an incretin hormone, prolonging the physiological effects of GLP‐1. In the present research work, a total of 12 glycinamide‐based compounds with aromatic substituents on the N‐terminus and heterocycles like piperidine, 4‐phenylpiperazine, and 6‐fluorobenzo[d]isoxazol‐3‐piperidine on the C‐terminus were synthesized and characterized. The synthesized compounds were subjected to in vitro DPP 4 inhibition assay. The promising compound JAG‐D2 was evaluated in vivo using OGTT assay in streptozotocin‐induced diabetic rats. JAG‐D2 produced a significant reduction in blood glucose levels at 20 mg/kg and 40 mg/kg doses when compared with a 1 mg/kg dose of the reference standard sitagliptin. The synthesized compounds occupied the active site of DPP 4 as demonstrated in molecular docking and MM‐GBSA analysis for rescoring on the basis of binding free energy. Molecular dynamics studies displayed the stability of the docked pose of JAG‐D2 in the catalytic site of DPP 4. All compounds exhibited compliance with Lipinski's rule of five, suggesting drug‐like properties.

Piceid dicarboxylic acid esters as potent α-glucosidase inhibitors and antiglycation agents: Synthesis, spectroscopic and molecular docking studies

Inhibition Mechanism of Α-Glucosidase by Three Geranylated Compounds: Kinetic, Spectroscopic and Molecular Docking

Design, synthesis and enzymatic inhibition evaluation of novel 4-Hydroxy Pd-C-III derivatives as α-glucosidase and PTP1B dual-target inhibitors

Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation

Multivalent glucosidase inhibitors based on perylene bisimide and iminosugar conjugates

Design and synthesis of epigallocatechin (EGC) analogs selective to inhibit α-amylase over α-glucosidases via the incorporation of caffeine acid and its derivatives

Exploration of Potent Human α ‐Glucosidase Inhibitors Using In Silico Approaches: Molecular Docking, DFT, Molecular Dynamics Simulations, and MMPBSA

Hypoglycemic peptide preparation from Bacillus subtilis fermented with Pyropia: Identification, molecular docking, and in vivo confirmation

Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum

Insight into the alpha-glucosidase-inhibiting mechanism of beta-PGG, a commonly occurring polyphenol in diets

In vitro α-amylase and α-glucosidase inhibition study of dihydropyrimidinones synthesized via one-pot Biginelli reaction in the presence of a green catalyst

Apigenin analogs as α-glucosidase inhibitors with antidiabetic activity

Investigation into the Mechanisms of Quercetin-3-o-glucuronide Inhibiting Α-Glucosidase Activity and Non-Enzymatic Glycation by Spectroscopy and Molecular Docking.

Exploration of the inhibitory mechanisms of trans-polydatin/resveratrol on α-glucosidase by multi-spectroscopic analysis, in silico docking and molecular dynamics simulation

Improving Regulation of Polymeric Proanthocyanidins and Tea Polyphenols against Postprandial Hyperglycemia <i>via</i> Acid-Catalyzed Transformation

Synthesis of 6-Chloro-2-aryl-1h-imidazo[4,5-b]pyridine Derivatives: Antidiabetic, Antioxidant, Β-Glucuronidase Inhibiton and Their Molecular Docking Studies.

Identification and Molecular Docking Study of Sugarcane Leaf‐derived Compounds As Potent Dipeptidyl Peptidase IV, Α‐glucosidase, and Α‐amylase Inhibitors

Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation

In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase

Inhibition of α‐glucosidase and α‐amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays

Computational Simulation Studies, Synthesis, In Vitro, and In Vivo Evaluation of Heterocyclically Substituted Glycinamide Derivatives as DPP 4 Inhibitors